What is going on with Centerview Healthcare?
Feels like every day Centerview is announcing another multi-billion dollar healthcare deal? Where is this domination coming from?
2023 Alone
- Seagen/Pfizer - $45bn
- Prometheus/Merck - $11bn
- Oak Street/CVS - $3bn
- Bellus/GSK - $2bn
- CinCor/AstraZeneca - $2bn
- Chiesi/Amryt - $2bn
- Amerisource/OneOncology - $2bn
Their partners such as Alan Hartman, Mark Robinson, and others. Were heavy weights at bulge bracket firms before moving to Centerview and have continued being on a tear. Not sure which partners were responsible for those deals but they an incredibly strong healthcare practice in general
Seems like while other HC IB coverage groups have been battling over their relationships with the big pharma players for the buy-side mandates (there have got to be 10 banks talking to Pfizer, AZ, Merck, etc. at any given point...), CVP has been focusing on their relationships with the sell-side instead. Pretty smart strategy.
Good team
My prayers are with centerview HC analysts
+ Provention / Sanofi - $3bn
Hence Tokat was named co-President of the firm. Seagen and Prometheus were his deals, he possibly had more from that list
Literally no idea why this is being given MS. This is true
Lmao I'm getting MS for this when it is 100% true...huh?
This has been called out multiple times on the last few posts this person / group of accounts has made. to the CVP intern/analyst who keeps posting these: Please stop spamming WSO every week with CVP hype posts. It’s extremely cringe and the same 3 accounts comment the same thing about Tokat or whatever.
edit: a few days later I get 2 MS thrown at this comment, almost immediately one after the other. I wonder how that could happen 🤔
OP is a verified 2nd year analyst and there were three posts in total probably. Are the centerview interns in the room with us now?
.
.
Yes, congrats to all 4 of his WSO accounts!
+1 MS, inaccurate
where is this DOMINATION COMING FROM???????
head of their group is known to be the best healthcare banker
+ Bellus $2B
del
It's unbelievable - does anyone know about their lateral hiring process?
Loool following.
Add in CTI (1.5bn) and Syneos (7.5bn) for casual week.I mean Jesus, does anyone have an approximation on their total deal value or fees so far this year? They may be in the 9 figures in terms of fees and q2 isn't even close to over.
Pfizer / Seagen alone pushed them over 9 figures
It's right in the proxy it was 8 figures...
Three deals make up almost a quarter of a billion dollars in fees: Seagen ($88M), Prometheus ($70.5M) and Oakstreet ($79M)
edit: someone please tell me why this is getting MS. These numbers are publicly available in 14A filings
Another announced today. Syneos Health for $7.1bn, co-advisor with BofA
Smh, you are the problem
Et voluptas ut reiciendis sapiente. Fugit vel molestias eum dolorum. Dolore quibusdam assumenda esse eum consequatur blanditiis repellat nobis.
Inventore et consequatur sit aut voluptatibus rerum. Eos ullam recusandae dolorem eius aut minus et. Vel est id optio laudantium accusamus enim omnis. Quidem quisquam quia quaerat.
Dolor possimus quisquam neque architecto. Quia nemo velit praesentium id sit maiores commodi. Rerum non est minus error alias ut. Enim rerum qui ut cupiditate libero facilis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...
Eos sit porro voluptas dolorum ea ut laboriosam qui. Quos saepe repudiandae itaque quia debitis eos et. Autem nulla amet nam sequi.
Est rerum est aliquid aut similique. Error laborum voluptas suscipit officiis eos quia ipsum. Aut praesentium ut quia reprehenderit earum ullam et consequatur.
Suscipit nemo nobis iusto esse ut dolores architecto. Soluta et quia quis ut. Et esse commodi voluptatem sit in libero. Quidem a fugiat quaerat odit. Et rerum quia quidem.